Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 78

1.

Antigen specific and MHC nonrestricted cytotoxicity of T cell receptor alpha beta+ and gamma delta+ human T cell clones isolated in IL-4.

Paliard X, Yssel H, Blanchard D, Waitz JA, deVries JE, Spits H.

J Immunol. 1989 Jul 15;143(2):452-7.

PMID:
2472439
2.

Sch 31828, a novel antibiotic from a Microbispora sp.: taxonomy, fermentation, isolation and biological properties.

Patel M, Conover M, Horan A, Loebenberg D, Marquez J, Mierzwa R, Puar MS, Yarborough R, Waitz JA.

J Antibiot (Tokyo). 1988 Jun;41(6):794-7. No abstract available.

3.

A novel tetracycline from Actinomadura brunnea. Fermentation, isolation and structure elucidation.

Patel M, Gullo VP, Hegde VR, Horan AC, Gentile F, Marquez JA, Miller GH, Puar MS, Waitz JA.

J Antibiot (Tokyo). 1987 Oct;40(10):1408-13.

4.

The biosynthesis of hazimicins: possible origin of isonitrile carbon.

Puar MS, Munayyer H, Hedge V, Lee BK, Waitz JA.

J Antibiot (Tokyo). 1985 Apr;38(4):530-2. No abstract available.

5.

A novel phenazine antifungal antibiotic, 1,6-dihydroxy-2-chlorophenazine. Fermentation, isolation, structure and biological properties.

Patel M, Hegde V, Horan AC, Gullo VP, Loebenberg D, Marquez JA, Miller GH, Puar MS, Waitz JA.

J Antibiot (Tokyo). 1984 Sep;37(9):943-8.

6.

Oxanthromicin, a novel antibiotic from Actinomadura.

Patel M, Horan AC, Gullo VP, Loebenberg D, Marquez JA, Miller GH, Waitz JA.

J Antibiot (Tokyo). 1984 Apr;37(4):413-5. No abstract available.

7.

The hazimicins, a new class of antibiotics. Taxonomy, fermentation, isolation, characterization and biological properties.

Marquez JA, Horan AC, Kalyanpur M, Lee BK, Loebenberg D, Miller GH, Patel M, Waitz JA.

J Antibiot (Tokyo). 1983 Sep;36(9):1101-8.

8.

Multistep bioconversion of 20-deoxo-20-dihydro-12,13-deepoxy-12,13-dehydrorosaranolide to 22-hydroxy-23-O-mycinosyl-20-deoxo-20-dihydro-12,13-deepoxy-rosaramicin.

Lee BK, Puar MS, Patel M, Bartner P, Lotvin J, Munayyer H, Waitz JA.

J Antibiot (Tokyo). 1983 Jun;36(6):742-4. No abstract available.

9.

Preparation and characterization of dedesosaminyl 5-O-mycaminosyl-10,11-dihydromycinamicin IV.

Lotvin J, Puar MS, Patel M, Lee BK, Schumacher D, Waitz JA.

J Antibiot (Tokyo). 1982 Oct;35(10):1407-8. No abstract available.

10.

Isolation and characterization of two 16-membered lactones: 20-deoxorosaramicin and 20-deoxo-12,13-desepoxy-12,13-dehydrorosaramicin aglycones, from a mutant strain of Micromonospora rosaria.

Vaughan RW, Lotvin J, Puar MS, Patel M, Kershner A, Kalyanpur MG, Marquez J, Waitz JA.

J Antibiot (Tokyo). 1982 Feb;35(2):251-3. No abstract available.

11.

Sch 29482, a new penem antibiotic: evaluation of in-vitro activity and effect of test conditions.

Hare RS, Miller GH, Naples L, Sabatelli F, Loebenberg D, Waitz JA.

J Antimicrob Chemother. 1982 Feb;9 Suppl C:7-16. No abstract available.

PMID:
7061377
12.

Evaluation of the in-vitro activity of Sch 29482.

Loebenberg D, Miller GH, Moss EL Jr, Oden E, Hare RS, Chung M, Waitz JA.

J Antimicrob Chemother. 1982 Feb;9 Suppl C:221-31. No abstract available.

PMID:
7061372
13.

Kijanimicin (Sch 25663), a novel antibiotic produced by Actinomadura kijaniata SCC 1256. Fermentation, isolation, characterization and biological properties.

Waitz JA, Horan AC, Kalyanpur M, Lee BK, Loebenberg D, Marquez JA, Miller G, Patel MG.

J Antibiot (Tokyo). 1981 Sep;34(9):1101-6.

14.

The biosynthesis of AR-5 (mycinamicins) antibiotics.

Puar MS, Lee BK, Munayyer H, Brambilla R, Waitz JA.

J Antibiot (Tokyo). 1981 May;34(5):619-20. No abstract available.

15.

Comparative in vitro and in vivo antifungal activity of tolnaftate and various undecylenates.

Loebenberg D, Parmegiani R, Hanks M, Waitz JA.

J Pharm Sci. 1980 Jun;69(6):739-41. No abstract available.

PMID:
7205600
16.

Evaluation of netilmicin susceptibility discs using bacteria with known aminoglycoside resistance patterns: correlation of in vitro and in vivo test results.

Waitz JA, Hare RS, Moss EL Jr, Sabatelli FJ, Schaffer TW, Waitz JA.

Scand J Infect Dis Suppl. 1980;Suppl 23:62-72.

PMID:
6937970
17.

Biosynthetic pathway leading to gentamicin C2b.

Lee BK, Nagabhushan TL, Condon RG, Shimonaski G, Kalyanpur MG, Patel M, Waitz JA.

Antimicrob Agents Chemother. 1979 Nov;16(5):589-91.

18.

Anti-pinworm activity of Sch 23154.

Loebenberg D, Nafissi-V MM, Antonacci B, Waitz JA.

J Parasitol. 1979 Oct;65(5):823-4. No abstract available.

PMID:
574540
19.

Renal uptake and nephrotoxicity of gentamicin during urinary alkalinization in rats.

Chiu PJ, Miller GH, Long JF, Waitz JA.

Clin Exp Pharmacol Physiol. 1979 May-Jun;6(3):317-26.

PMID:
38026
20.

Anthelmintic activity of Sch 20350 in dogs.

Loebenberg D, Nafissi-V MM, Antonacci B, Waitz JA.

J Parasitol. 1979 Apr;65(2):233. No abstract available.

PMID:
286783
21.
22.

Antibiotic biosynthesis by cofermentation of blocked mutants of two Micromonospora species.

Lee BK, Nagabhushan TL, Condon RG, Cooper AB, Waitz JA.

Antimicrob Agents Chemother. 1978 Jul;14(1):73-7.

23.

Method for qualitative determination of 2-deoxystreptamine.

Lee BK, Condon RG, Patel M, Oden EM, Waitz JA.

Antimicrob Agents Chemother. 1978 Jul;14(1):157-8.

24.

Anthelmintic activity of tioxidazole (Sch 21480) against gastrointestinal roundworms.

Panitz E, Daniels PJ, Loebenberg D, Nafissi MM, Waitz JA.

Experientia. 1978 Jun 15;34(6):733.

PMID:
658283
25.
26.

Chemotherapeutic evaluation of 5-episisomicin (Sch 22591), a new semisynthetic aminoglycoside.

Waitz JA, Miller GH, Moss E Jr, Chiu PJ.

Antimicrob Agents Chemother. 1978 Jan;13(1):41-8.

27.

Intestinal helminths and protozoa of New Jersey dogs.

Loebenberg D, Waitz JA.

J Parasitol. 1977 Dec;63(6):1139-40. No abstract available.

PMID:
592049
28.

Renal pharmacology of netilmicin.

Chiu PJ, Miller GH, Brown AD, Long JF, Waitz JA.

Antimicrob Agents Chemother. 1977 May;11(5):821-5.

29.

Stability of gentamicin sulfate admixture.

Chrai SS, Phelan KR, Speicher ER, Waitz JA.

Am J Hosp Pharm. 1977 Apr;34(4):348. No abstract available.

PMID:
860719
30.

Biological activity of netilmicin, a broad-spectrum semisynthetic aminoglycoside antibiotic.

Miller GH, Arcieri G, Weinstein MJ, Waitz JA.

Antimicrob Agents Chemother. 1976 Nov;10(5):827-36.

31.

A new broad spectrum aminoglycoside antibiotic, G-52, produced by Micromonospora zionensis.

Marquez JA, Wagman GH, Testa RT, Waitz JA, Weinstein MJ.

J Antibiot (Tokyo). 1976 May;29(5):483-7.

32.
33.

New polyene antifungal antibiotic produced by a species of Actinoplanes.

Wagman GH, Testa RT, Patel M, Marquez JA, Oden EM, Waitz JA, Weinstein MJ.

Antimicrob Agents Chemother. 1975 Apr;7(4):457-61.

34.

Verdamicin, a new broad spectrum aminoglycoside antibiotic.

Weinstein MJ, Wagman GH, Marquez JA, Testa RT, Waitz JA.

Antimicrob Agents Chemother. 1975 Mar;7(3):246-9.

35.

Biological activity of antibiotic G-418, a new micromonospora-produced aminoglycoside with activity against protozoa and helminths.

Waitz JA, Sabatelli F, Menzel F, Moss EL Jr.

Antimicrob Agents Chemother. 1974 Nov;6(5):579-81.

36.

Comparison of enzymatic and microbiological gentamicin assays.

Smith AL, Waitz JA, Smith DH, Oden EM, Emerson BB.

Antimicrob Agents Chemother. 1974 Sep;6(3):316-9.

38.

Biological activity of Sch 14342, an aminoglycoside antibiotic coproduced in the gentamicin fermentation.

Waitz JA, Moss EL Jr, Oden EM, Wagman GH, Weinstein MJ.

Antimicrob Agents Chemother. 1972 Dec;2(6):464-9.

39.

Comparative activity of sisomicin, gentamicin, kanamycin, and tobramycin.

Waitz JA, Moss EL Jr, Drube CG, Weinstein MJ.

Antimicrob Agents Chemother. 1972 Dec;2(6):431-7.

40.

A new Micromonospora-produced macrolide antibiotic, rosamicin.

Wagman GH, Waitz JA, Marquez J, Murawaski A, Oden EM, Testa RT, Weinstein MJ.

J Antibiot (Tokyo). 1972 Nov;25(11):641-6. No abstract available.

41.

Biological studies with rosamicin, a new Micromonospora-produced macrolide antibiotic.

Waitz JA, Drube CG, Moss EL Jr, Weinstein MJ.

J Antibiot (Tokyo). 1972 Nov;25(11):647-52. No abstract available.

42.

Biological aspects of the interaction between gentamicin and carbenicillin.

Waitz JA, Drube CG, Moss EL Jr, Oden EM, Bailey JV.

J Antibiot (Tokyo). 1972 Apr;25(4):219-25. No abstract available.

43.

Aspects of the chronic toxicity of gentamicin sulfate in cats.

Waitz JA, Moss EL Jr, Weinstein MJ.

J Infect Dis. 1971 Dec;124 Suppl:S125-29. No abstract available.

PMID:
5315998
44.

A virulent nosocomial Klebsiella with a transferable R factor for gentamicin: emergence and suppression.

Martin CM, Ikari NS, Zimmerman J, Waitz JA.

J Infect Dis. 1971 Dec;124 Suppl:S24-9. No abstract available.

PMID:
5126246
45.

Microbiologic studies related to bacterial resistance to gentamicin.

Weinstein MJ, Drube CG, Moss EL Jr, Waitz JA.

J Infect Dis. 1971 Dec;124 Suppl:S11-7. No abstract available.

PMID:
5001619
46.

Gentamicin antibiotics. 4. Some condensation products of gentamicin C2 with aromatic and aliphatic aldehydes.

Cooper DJ, Weinstein J, Waitz JA.

J Med Chem. 1971 Nov;14(11):1118-20. No abstract available.

PMID:
5000476
47.
48.

Biological activity of megalomicin A phosphate, a water-soluble salt of megalomicin A.

Waitz JA, Moss EL Jr, Oden EM, Weinstein MJ.

J Antibiot (Tokyo). 1971 May;24(5):310-6. No abstract available.

49.

Antibiotic 6640, a new Micromonospora-produced aminoglycoside antibiotic.

Weinstein MJ, Marquez JA, Testa RT, Wagman GH, Oden EM, Waitz JA.

J Antibiot (Tokyo). 1970 Nov;23(11):551-4. No abstract available.

50.

Antibiotic 6640. 3. Biological studies with antibiotic 6640, a new broad-spectrum aminoglycoside antibiotic.

Waitz JA, Moss EL Jr, Oden EM, Weinstein MJ.

J Antibiot (Tokyo). 1970 Nov;23(11):559-65. No abstract available.

Supplemental Content

Loading ...
Support Center